Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion type Assertion NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_head.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion description "[Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_provenance.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion evidence source_evidence_literature NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_provenance.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion SIO_000772 25721604 NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_provenance.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion wasDerivedFrom befree-2016 NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_provenance.
- NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_assertion wasGeneratedBy ECO_0000203 NP1266601.RAsaTXnJULrNEE5ObxjHbYXvF_sXf51O6aKa5LerIZqL8130_provenance.